Şunu aradınız:: vasoconstrictors (İngilizce - Maltaca)

caution should be exercised in patients suffering from migraine who are currently being treated with ergot alkaloid vasoconstrictors.
għandu jkun hemm kawtela f’ pazjenti li jbatu minn emikranja li jkunu qed jiġu kkurati b’ vażikostritturi tat- tip ergot alkalojd.

caution should be exercised in patients suffering from migraine who are currently being treated with ergot alkaloid vasoconstrictors (see section 4.5).
għandu jkun hemm kawtela f’pazjenti li jbatu minn emikranja li jkunu qed jiġu kkurati b’vażikostritturi tat-tip ergot alkalojd (ara sezzjoni 4.5).

hypotension does not normally require specific treatment but, where needed, users should be ready to intervene with dose reduction, fluids and/or vasoconstrictors .
pressjoni baxxa normalment ma tkunx teħtieġ kura speċifika iżda, fejn meħtieġ, l-utenti għandhom ikunu lesti biex jintervjenu bi tnaqqis fid-doża, fluwidi u/jew sustanzi li jikkawżaw tidjiq tal-kanali tad-demm.

other vasoconstrictors used as nasal decongestant, by oral or nasal route (phenylpropanolamine, phenylephrine, ephedrine, oxymetazoline, naphazoline…): risk of vasoconstriction.
sustanzi oħra li jikkawżaw vażokostrizzjoni wżati bħala sustanzi kontra l-konġestjoni fl-imnieħer, li jingħataw mill-ħalq jew mill-imnieħer (phenylpropanolamine, phenylephrine, ephedrine, oxymetazoline, naphazoline…): riskju ta’ vażokostrizzjoni.

the neurohormone endothelin-1 (et-1) is one of the most potent vasoconstrictors known and can also promote fibrosis, cell proliferation, cardiac hypertrophy, and remodeling and is pro-inflammatory.
32 in- newro- ormon endothelin- 1 (et- 1) huwa wieħed mis- sustanzi magħrufa l- iktar qawwija li jdejjaq il - vini u l- arterji u li jista ’ jikkawża wkoll il- fibrożi, il- proliferazzjoni taċ- ċelluli, it- tkabbir tal- qalb, u jista ’ jerġa ’ jimmudella l- qalb u jippromwovi l- infjammazzjoni.